BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20457523)

  • 1. CHIPS binds to the phosphorylated N-terminus of the C5a-receptor.
    Bunschoten A; Feitsma LJ; Kruijtzer JA; de Haas CJ; Liskamp RM; Kemmink J
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3338-40. PubMed ID: 20457523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.
    Ippel JH; de Haas CJ; Bunschoten A; van Strijp JA; Kruijtzer JA; Liskamp RM; Kemmink J
    J Biol Chem; 2009 May; 284(18):12363-72. PubMed ID: 19251703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
    Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
    J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
    Haas PJ; de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA; Dijkstra K; Scheek RM; Fan H; Kruijtzer JA; Liskamp RM; Kemmink J
    J Mol Biol; 2005 Nov; 353(4):859-72. PubMed ID: 16213522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
    Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
    J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies.
    Gustafsson E; Rosén A; Barchan K; van Kessel KP; Haraldsson K; Lindman S; Forsberg C; Ljung L; Bryder K; Walse B; Haas PJ; van Strijp JA; Furebring C
    Protein Eng Des Sel; 2010 Feb; 23(2):91-101. PubMed ID: 19959567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.
    Liu ZJ; Yang YJ; Jiang L; Xu YC; Wang AX; Du GH; Gao JM
    Acta Pharmacol Sin; 2011 Aug; 32(8):1038-44. PubMed ID: 21706042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
    Wright AJ; Higginbottom A; Philippe D; Upadhyay A; Bagby S; Read RC; Monk PN; Partridge LJ
    Mol Immunol; 2007 Apr; 44(10):2507-17. PubMed ID: 17258808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.
    Nikiforovich GV; Baranski TJ
    Biochem Biophys Res Commun; 2009 Dec; 390(3):481-4. PubMed ID: 19799858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
    Suvorova ES; Gripentrog JM; Miettinen HM
    Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.
    Haas PJ; de Haas CJ; Kleibeuker W; Poppelier MJ; van Kessel KP; Kruijtzer JA; Liskamp RM; van Strijp JA
    J Immunol; 2004 Nov; 173(9):5704-11. PubMed ID: 15494522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.
    Gustafsson E; Haas PJ; Walse B; Hijnen M; Furebring C; Ohlin M; van Strijp JA; van Kessel KP
    BMC Immunol; 2009 Mar; 10():13. PubMed ID: 19284584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.
    Bunschoten A; Ippel JH; Kruijtzer JA; Feitsma L; de Haas CJ; Liskamp RM; Kemmink J
    Amino Acids; 2011 Feb; 40(2):731-40. PubMed ID: 20683629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells.
    Giannini E; Boulay F
    J Immunol; 1995 Apr; 154(8):4055-64. PubMed ID: 7706744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of membrane translocating peptides to identify sites of interaction between the C5a receptor and downstream effector proteins.
    Auger GA; Smith BM; Pease JE; Barker MD
    Immunology; 2004 Aug; 112(4):590-6. PubMed ID: 15270730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.